These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 24415460)

  • 41. Identification of a conserved linear epitope on the VP1 protein of serotype O foot-and-mouth disease virus by neutralising monoclonal antibody 8E8.
    Yang D; Zhang C; Zhao L; Zhou G; Wang H; Yu L
    Virus Res; 2011 Jan; 155(1):291-9. PubMed ID: 20974198
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Trivalency of a Nanobody Specific for the Human Respiratory Syncytial Virus Fusion Glycoprotein Drastically Enhances Virus Neutralization and Impacts Escape Mutant Selection.
    Palomo C; Mas V; Detalle L; Depla E; Cano O; Vázquez M; Stortelers C; Melero JA
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6498-6509. PubMed ID: 27550346
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An investigation of the genetic basis of increased susceptibility to neutralization by anti-fusion glycoprotein antibody arising on passage of human respiratory syncytial virus in cell culture.
    Hiriote W; Gias EL; Welsh SH; Toms GL
    J Med Virol; 2015 Jan; 87(1):130-40. PubMed ID: 24861209
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Glycosylation is not necessary for recognition of the fusion glycoprotein domain of the human respiratory syncytial virus by a polyclonal antibody.
    Lim SH; Jahanshiri F; Jalilian FA; Rahim RA; Sekawi Z; Yusoff K
    Acta Virol; 2010; 54(3):181-7. PubMed ID: 20822310
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A potent broadly neutralizing human RSV antibody targets conserved site IV of the fusion glycoprotein.
    Tang A; Chen Z; Cox KS; Su HP; Callahan C; Fridman A; Zhang L; Patel SB; Cejas PJ; Swoyer R; Touch S; Citron MP; Govindarajan D; Luo B; Eddins M; Reid JC; Soisson SM; Galli J; Wang D; Wen Z; Heidecker GJ; Casimiro DR; DiStefano DJ; Vora KA
    Nat Commun; 2019 Sep; 10(1):4153. PubMed ID: 31515478
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Preparation and identification of mouse anti-human monoclonal antibody against P protein of respiratory syncytial virus].
    Si J; Zhan L; Yi H; Zhao M; Zhang W; Sun Y; Zheng Z; Xia N
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2019 Nov; 35(11):1035-1041. PubMed ID: 31879001
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Characterization of the epitope for anti-human respiratory syncytial virus F protein monoclonal antibody 101F using synthetic peptides and genetic approaches.
    Wu SJ; Schmidt A; Beil EJ; Day ND; Branigan PJ; Liu C; Gutshall LL; Palomo C; Furze J; Taylor G; Melero JA; Tsui P; Del Vecchio AM; Kruszynski M
    J Gen Virol; 2007 Oct; 88(Pt 10):2719-2723. PubMed ID: 17872524
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Expression and antigenicity of recombinant human respiratory syncytial virus glycoproteins having different affinity tags.
    Lee HS; Kim AR; Kim K; Lee WJ; Kim SS; Kim YJ
    Protein Expr Purif; 2017 Apr; 132():1-8. PubMed ID: 28042093
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Production of monoclonal antibodies to the human respiratory syncytial virus].
    Samolovich MP; Sukhubaevskaia LP; Klimovich VB; Sominina AA
    Vestn Ross Akad Med Nauk; 1994; (9):18-21. PubMed ID: 7532487
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Biological activity, binding site and affinity of monoclonal antibodies to the fusion protein of respiratory syncytial virus.
    West WH; Lounsbach GR; Bourgeois C; Robinson JW; Carter MJ; Crompton S; Duhindan N; Yazici ZA; Toms GL
    J Gen Virol; 1994 Oct; 75 ( Pt 10)():2813-9. PubMed ID: 7931172
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characterization of chimpanzee/human monoclonal antibodies to vaccinia virus A33 glycoprotein and its variola virus homolog in vitro and in a vaccinia virus mouse protection model.
    Chen Z; Earl P; Americo J; Damon I; Smith SK; Yu F; Sebrell A; Emerson S; Cohen G; Eisenberg RJ; Gorshkova I; Schuck P; Satterfield W; Moss B; Purcell R
    J Virol; 2007 Sep; 81(17):8989-95. PubMed ID: 17581986
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Epitope mapping of human respiratory syncytial virus 22K transcription antitermination factor: role of N-terminal sequences in protein folding.
    García-Barreno B; Steel J; Payá M; Martínez-Sobrido L; Delgado T; Yeo RP; Melero JA
    J Gen Virol; 2005 Apr; 86(Pt 4):1103-1107. PubMed ID: 15784904
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Involvement of the complement system in the protection of mice from challenge with respiratory syncytial virus Long strain following passive immunization with monoclonal antibody 18A2B2.
    Corbeil S; Seguin C; Trudel M
    Vaccine; 1996 Apr; 14(6):521-5. PubMed ID: 8782350
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mapping of a fusion related epitope of the respiratory syncytial virus fusion protein.
    Paradiso PR; Hu BT; Arumugham R; Hildreth S
    Vaccine; 1991 Apr; 9(4):231-7. PubMed ID: 1711741
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Monoclonal antibodies to the fusion protein of bovine respiratory syncytial virus.
    Mulkey KM; Anderson GA
    J Clin Microbiol; 1991 Sep; 29(9):2038-40. PubMed ID: 1723078
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Production and characterization of monoclonal antibodies to bovine respiratory syncytial virus.
    Underwood WJ; McCallum Q; Velicer LF; Mufson MA; Baker JC
    Vet Microbiol; 1995 Feb; 43(2-3):261-74. PubMed ID: 7740764
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Development of Human Monoclonal Antibodies Against Respiratory Syncytial Virus Using a High Efficiency Human Hybridoma Technique.
    Alvarado G; Crowe JE
    Methods Mol Biol; 2016; 1442():63-76. PubMed ID: 27464688
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inhibition of cell fusion by neutralizing monoclonal antibodies to F1 protein of turkey rhinotracheitis virus.
    Tanaka M; Obi T; Takuma H; Kokumai N; Higashihara R; Hiramatsu K; Shimizu Y
    J Vet Med Sci; 1996 Jun; 58(6):581-2. PubMed ID: 8811632
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The C-terminal third of human respiratory syncytial virus attachment (G) protein is partially resistant to protease digestion and is glycosylated in a cell-type-specific manner.
    García-Beato R; Melero JA
    J Gen Virol; 2000 Apr; 81(Pt 4):919-27. PubMed ID: 10725417
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Generation of monoclonal antibodies specific of the postfusion conformation of the Pneumovirinae fusion (F) protein.
    Rodríguez L; Olmedillas E; Mas V; Vázquez M; Cano O; Terrón MC; Luque D; Palomo C; Melero JA
    J Virol Methods; 2015 Nov; 224():1-8. PubMed ID: 26275682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.